Active Comparator Design
Active Comparator Design is a type of clinical study design in which the intervention under investigation is compared against an already established, actively used treatment rather than a placebo or no treatment, thereby enabling the assessment of relative effectiveness or safety within real-world evidence research.
202
Publications
15.8K
Citations
1.9K
Authors
847
Institutions
Publications per year
2017–2026
118
Parents
202
Trials to assess equivalence: the importance of rigorous methods: Fig 1
Byron Jones, Philip Jarvis, John A. Lewis et al. · BMJ · 1996 · 1K citations
Andrew Blauvelt, Kim Papp, C.E.M. Griffiths et al. · Journal of the American Academy of Dermatology · 2017 · 860 citations · Full text
Juan P. Frías, Michael A. Nauck, Joanna Van et al. · The Lancet · 2018 · 799 citations
Kristian Reich, April W. Armstrong, Peter Foley et al. · Journal of the American Academy of Dermatology · 2017 · 731 citations · Full text
1–5 of 202
1.9K
5
h-index
5
h-index
5
h-index
5
h-index
5
h-index
1–5 of 1.9K
847
Merck & Co., Inc., Rahway, NJ, USA (United States)
Rahway, United States
12 h-index
55 publications
4.1K citations
Harvard University
Cambridge, United States
9 h-index
25 publications
1.8K citations

Karolinska Institutet
Stockholm, Sweden
9 h-index
42 publications
3K citations

Jewish General Hospital
Montreal, Canada
8 h-index
32 publications
1.6K citations
Eli Lilly (United States)
Indianapolis, United States
7 h-index
32 publications
5.7K citations
University of North Carolina at Chapel Hill
Chapel Hill, United States
7 h-index
19 publications
2.5K citations

McGill University
Montreal, Canada
7 h-index
22 publications
1K citations

Brigham and Women's Hospital
Boston, United States
7 h-index
18 publications
738 citations
1–8 of 847
6 publications · 531 citations
6
h-index
5 publications · 265 citations
5
h-index
CMRO · 5 publications · 191 citations
5
h-index
5 publications · 171 citations
5
h-index
5 publications · 505 citations
5
h-index
1–5